It is well known that EPA and DHA support cardiovascular and metabolic health through several mechanisms.
The Global Organization for EPA and DHA Omega-3s is making a push to spread awareness of omega-3s among healthcare professionals, including nurse practitioners, physician’s assistants, and pharmacists, with the launch of its new Fats for Life website.
The review found that the combination of omega-3s and statins for heart health can sometimes be complementary, but can also be antagonistic. The authors note that further intervention studies are needed to explore the interaction.
A new clinical trial is underway to examine the effects of krill oil on those suffering from lupus.
Amarin Corp., maker of Vascepa, a high-concentration EPA-only omega-3 drug for heart health, published the topline results from its large-scale Reduction of Cardiovascular Events with EPA Intervention Trial (REDUCE-IT).
Omega-3 supplementation improved immune function in GI cancer patients post-surgery, says meta-analysis
Post-surgical immune function as well as recovery outcomes improved for GI cancer patients after short-term omega-3 supplementation, according to meta-analysis.
An Australian company called Nuseed, a subsidiary of Nufarm Ltd., announced that USDA has deregulated the company’s proprietary omega-3 canola for cultivation in the U.S.
Higher omega-3 index linked to reduced cognitive depression symptoms in heart failure patients, study finds
Higher omega-3 levels may be linked to reduced cognitive depression symptoms in heart failure patients, according to a study recently published in the Journal of the American College of Cardiology’s Heart Failure.
Bill Harris, PhD, omega-3 researcher and founder of OmegaQuant, says a recent Cochrane report is biased because it ignores a large body of evidence showing favorable effects of EPA and DHA on cardiovascular risk.
A heart-healthy lifestyle should start early in life. Omega-3 fatty acid supplementation can help.